Phenelzine

DRUG3 trials

Sponsors

Celgene, University of California, San Francisco

Conditions

DepressionDepressive Disorder, MajorHealthy VolunteerHealthy VolunteersMajor Depressive Disorder

Phase 1

Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response

CompletedNCT03694119

CelgeneHealthy Volunteer

Start: 2018-07-24End: 2019-01-08Updated: 2019-07-19

Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants

CompletedNCT04978298

CelgeneHealthy Volunteers

Start: 2021-07-19End: 2023-02-26Updated: 2023-08-31

Phase 4

Precision Care for Major Depressive Disorder

Enrolling by invitationNCT06580041

University of California, San FranciscoDepression, Depressive Disorder, Major, Major Depressive Disorder

Start: 2024-11-12End: 2029-09-01Target: 150Updated: 2025-09-05